• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[三种神经囊尾蚴病免疫诊断方法的有效性:1960 - 2014年文献系统评价及荟萃分析]

[Validity of three methods for inmuno-diagnostic of neurocysticercosis: systematic review of the literature with meta-analysis 1960-2014].

作者信息

Cardona-Arias Jaiberth Antonio, Carrasquilla-Agudelo Yoneida Elena, Restrepo-Posada Deisy Cristina

机构信息

Grupo de investigación Salud y Sostenibilidad, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia.

出版信息

Rev Chilena Infectol. 2017 Feb;34(1):33-44. doi: 10.4067/S0716-10182017000100005.

DOI:10.4067/S0716-10182017000100005
PMID:28394979
Abstract

INTRODUCTION

The screening of neurocysticercosis is complex and immunological methods have varying validity.

OBJECTIVE

To evaluate the validity of ELISA for antigen and antibody, and EITB for antibody in the screening of neurocysticercosis.

METHODS

Meta-analysis of diagnostic tests with an ex-ante protocol implemented in five databases with 15 search strategies, ensuring reproducibility in the selection and extraction of information. Sensitivity, specificity, likelihood ratios (LR), diagnostic odds ratio and ROC curve were estimated in MetaDiSc, and predictive values, and Youden index were estimated in Epidat.

RESULTS

EITB presented sensitivity of 85.7% (95% CI 83.5-87.7), specificity 93.9% (95% CI = 92.7-95.0), PLR 19.6 (95% CI = 8,6-44.6), NLR 0.16 (95% CI = 0.12-0.21), OR diagnostic 136.2 (95% CI = 54.7-342.6) and area under the curve 0.926. In ELISA for antibody sensitivity was 87.5% (95% CI = 86.1-88.8), specificity 92.2% (95% CI = 91.4-93.0), PLR 11.3 (95% CI = 8.45-15.11), NLR 0.15 (95% CI = 0.13-0.18), diagnostic OR 87.4 (95% CI = 60.1-127.1) and area under the curve 0.950. ELISA for antigen showed low diagnostic validity. No differences were found in these parameters by sample, antigen or antibody type.

CONCLUSION

ELISA for antibodies and EITB have a similar diagnostic value, detection of serum and CSF showed a similar validity.

摘要

引言

神经囊尾蚴病的筛查较为复杂,免疫方法的有效性各不相同。

目的

评估酶联免疫吸附测定(ELISA)检测抗原和抗体以及酶联免疫电转印印迹法(EITB)检测抗体在神经囊尾蚴病筛查中的有效性。

方法

采用事前方案对诊断试验进行荟萃分析,在五个数据库中运用15种检索策略,确保信息选择和提取的可重复性。在MetaDiSc中估计敏感性、特异性、似然比(LR)、诊断比值比和ROC曲线,在Epidat中估计预测值和尤登指数。

结果

EITB的敏感性为85.7%(95%置信区间83.5 - 87.7),特异性为93.9%(95%置信区间 = 92.7 - 95.0),阳性似然比为19.6(95%置信区间 = 8.6 - 44.6),阴性似然比为0.16(95%置信区间 = 0.12 - 0.21),诊断比值比为136.2(95%置信区间 = 54.7 - 342.6),曲线下面积为0.926。ELISA检测抗体时,敏感性为87.5%(95%置信区间 = 86.1 - 88.8),特异性为92.2%(95%置信区间 = 91.4 - 93.0),阳性似然比为11.3(95%置信区间 = 8.45 - 15.11),阴性似然比为0.15(95%置信区间 = 0.13 - 0.18),诊断比值比为87.4(95%置信区间 = 60.1 - 127.1),曲线下面积为0.950。ELISA检测抗原显示出较低的诊断有效性。在这些参数方面,未发现样本、抗原或抗体类型存在差异。

结论

ELISA检测抗体和EITB具有相似的诊断价值,检测血清和脑脊液显示出相似的有效性。

相似文献

1
[Validity of three methods for inmuno-diagnostic of neurocysticercosis: systematic review of the literature with meta-analysis 1960-2014].[三种神经囊尾蚴病免疫诊断方法的有效性:1960 - 2014年文献系统评价及荟萃分析]
Rev Chilena Infectol. 2017 Feb;34(1):33-44. doi: 10.4067/S0716-10182017000100005.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.症状和胸部 X 线筛查在 HIV 阴性的成年人和 HIV 状态未知的成年人中的活动性肺结核。
Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2.
9
Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions.三维盐水灌注超声与二维盐水灌注超声在诊断腔内局灶性病变中的比较。
Cochrane Database Syst Rev. 2017 May 5;5(5):CD011126. doi: 10.1002/14651858.CD011126.pub2.
10
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.

引用本文的文献

1
From laboratory to clinical practice: an update of the immunological and molecular tools for neurocysticercosis diagnosis.从实验室到临床实践:神经囊尾蚴病诊断的免疫学和分子工具更新
Front Parasitol. 2024 Jul 1;3:1394089. doi: 10.3389/fpara.2024.1394089. eCollection 2024.
2
Accuracy of immunological tests on serum and urine for diagnosis of Taenia solium neurocysticercosis: A systematic review.血清和尿液免疫试验诊断猪带绦虫性神经囊尾蚴病的准确性:系统评价。
PLoS Negl Trop Dis. 2024 Nov 11;18(11):e0012643. doi: 10.1371/journal.pntd.0012643. eCollection 2024 Nov.
3
Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico.
免疫诊断人囊尾蚴病:墨西哥血清诊断试验的比较性能。
Parasitol Res. 2019 Oct;118(10):2891-2899. doi: 10.1007/s00436-019-06425-4. Epub 2019 Aug 15.